Kelly, Conor W <br/><br/>
Total and differential white blood cell counts, inflammatory markers, adipokines, and incident metabolic syndrome in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.  [electronic resource] 

 -  Schizophrenia research  07 2019 
 - 193-197 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1573-2509 
<br/><br/><label>Standard No.: </label>10.1016/j.schres.2019.04.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipokines--blood<br/>Adult<br/>Antipsychotic Agents--adverse effects<br/>C-Reactive Protein<br/>Female<br/>Humans<br/>Inflammation--blood<br/>Interleukin-6--blood<br/>Leptin--blood<br/>Leukocyte Count<br/>Male<br/>Metabolic Syndrome--blood<br/>Middle Aged<br/>Schizophrenia--blood